Table 1.
Baseline subject characteristics in the fracture and the BMD studies
| Subject characteristics | Fracture study | BMD study |
|---|---|---|
| n | 795 | 651 |
| Age | 59.8 +/- 12.8 | 58.6 +/- 12.3 |
| Female gender, (%) | 553/795 (69.6%) | 455/651 (69.9%) |
| Women estrogen sufficient, (%) | 261/553 (47.2%) | 228/455 (50.1%) |
| Body Mass Index, kg/m2 | 26.1 +/- 4.7 | 26.0 +/- 4.7 |
| Change of BMI, kg/m2 | 0.56 +/- 1.71 | 0.59 +/- 1.69 |
| Physical activity, kcal/day | 1548 +/- 589 | 1576 +/- 806 |
| Family history of osteoporosis, (%) | 71/511 (13.9%) | 60/415 (14.5%) |
| Calcium intake, mg/day | 889 +/- 550 | 885 +/- 551 |
| Serum 25(OH) Vitamin D, nmol/l | 75.1 +/- 28.4 | 74.9 +/- 28.4 |
| Smoking, (%) | 154/438 (35.2%) | 113/352 (32.1%) |
| Caucasian race, (%) | 792 (99.6%) | 647 (99.4%) |
| Kidney Disease, (%) | 119/733 (16.2%) | 118/632 (18.7%) |
| Thiazide medications, (%) | 66/795 (8.3%) | 52/651 (8.0%) |
| Bisphosphonates, (%) | 8/795 (1.0%) | 6/651 (0.9%) |
*mean +/- sd, nmol/l = nanomole per litre